Breaking News

Financial Report: Hospira

Results were strong last quarter, driven by specialty injectables

The company saw growth last quarter, with much of that fueled by demand for specialty injectables. 2Q Revenues: $1,136 billion  +10.7% 2Q Earnings: $71 billion  +115% YTD Revenue: $2,187 billion  +14.5% YTD Earnings: $139 billion  +417.6%...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters